Sign up to save your podcasts
Or
Share 503A Compound Tirzepatide Deadline Is Here, What Next? // OTP TWD 2.18.25
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
503A Compound Tirzepatide Deadline Is Here, What Next? // OTP TWD 2.18.25
š Book Relaunch: The book āDecoding GLP-1ā is back on Amazon, now priced at $10, thanks to community advocacy.
ā³ Compounding Update: The FDA has delayed enforcement on 503A pharmacies until a court ruling expected by February 25.
š¬ Fat Cell Research: New findings suggest fat cells may help tailor obesity treatments based on individual profiles.
š PBM Concerns: Advocacy for Pharmacy Benefit Manager reform highlights their impact on drug prices and patient access.
š Investor Insights: Amalin shows promise in obesity treatment, with new research indicating its effects on appetite and food choices.
š„ Upcoming Medications: Kagema is anticipated to hit the market in early 2026, alongside new developments from various companies.
š Community Engagement: The podcast encourages listeners to subscribe and support ongoing efforts in obesity medicine discussions
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
View all episodes
By Bleav, Dave Knapp Founder of On The Pen
4.9
280280 ratings
š Book Relaunch: The book āDecoding GLP-1ā is back on Amazon, now priced at $10, thanks to community advocacy.
ā³ Compounding Update: The FDA has delayed enforcement on 503A pharmacies until a court ruling expected by February 25.
š¬ Fat Cell Research: New findings suggest fat cells may help tailor obesity treatments based on individual profiles.
š PBM Concerns: Advocacy for Pharmacy Benefit Manager reform highlights their impact on drug prices and patient access.
š Investor Insights: Amalin shows promise in obesity treatment, with new research indicating its effects on appetite and food choices.
š„ Upcoming Medications: Kagema is anticipated to hit the market in early 2026, alongside new developments from various companies.
š Community Engagement: The podcast encourages listeners to subscribe and support ongoing efforts in obesity medicine discussions
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
More shows like On The Pen With Dave Knapp
View all
The Hormone Solution with Karen Martel
338 Listeners
Everyday Wellness: Midlife Hormones, Health, and Science for Women 35+
1,227 Listeners
The Holistic GLP-1 Podcast with Elizabeth McGann
50 Listeners
The Hunter Williams Podcast
84 Listeners
The Dr. Tyna Show
1,657 Listeners
Docs Who Lift
390 Listeners
The Obesity Guide with Matthea Rentea MD
224 Listeners
The Plus SideZ: A Guide to GLP-1 & Metabolic Health
201 Listeners
Game-Changing Health
32 Listeners
The Peptide Podcast
94 Listeners
The Dr. Francavilla Show
61 Listeners
Fat Science
157 Listeners
GLP-1 Hub: Support, Community, and Weight Loss
18 Listeners
GLP-1 Tribe
25 Listeners
Today's discussion on unraveling BPC 157 Peptide
20 Listeners